Ondansetron
Back to searchMolecule Structure
Scientific Name
Ondansetron
Description of the Drug
Ondansetron is a serotonin 5-HT3 receptor antagonist used to prevent nausea and vomiting in cancer chemotherapy and postoperatively.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00904
http://www.drugbank.ca/drugs/DB00904
Brand Name(s)
Ondansetron, Zofran, Zofran odt, Zuplenz
Company Owner(s)
Glaxosmithkline, Claris Pharmaservices, Nesher Pharmaceuticals Usa Llc, American Regent Inc, Aquestive Therapeutics Inc, Mylan Pharmaceuticals Inc, Novartis Pharmaceuticals Corp, Atlantide Pharmaceuticals Ag, Emcure Pharmaceuticals Ltd, Rising Pharma Holdings Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Serotonin 3a (5-HT3a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1899 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4542 | |||
| PharmGKB | PA450705 | |||
| Human Metabolome Database | HMDB0005035 | |||
| DrugBank | DB00904 | |||
| PubChem: Thomson Pharma | 14873468 | |||
| PubChem | 4595 | |||
| Mcule | MCULE-9438746800 | |||
| LINCS | LSM-1375 | |||
| Nikkaji | J245.610I | |||
| PDBe | S87 | |||
| BindingDB | 85330 | |||
| EPA CompTox Dashboard | DTXSID8023393 | |||
| DrugCentral | 1992 | |||
| Brenda | 122952 | |||
| ChemicalBook | CB6340203 | CB9340204 | ||
| Guide to Pharmacology | 2290 | |||
| rxnorm | ONDANSETRON | ZOFRAN | ONDANSETRON HYDROCHLORIDE | ZUPLENZ |
| KEGG Ligand | C07325 | |||
| ChEBI | 7773 |
